Gabriel Oaxaca, MD

Director of Immunohistochemistry
Board-Certified Dermatopathologist
Dr. Oaxaca

Dr. Gabriel G. Oaxaca is board certified in dermatopathology and anatomic & clinical pathology and is a Diplomate of the American Board of Pathology. He received his medical degree from the esteemed Baylor College of Medicine in Houston, TX. Dr. Oaxaca completed his AP/CP residency training in 2021 at the Cleveland Clinic Foundation in Cleveland, Ohio, followed by a dermatopathology fellowship in 2022.

Throughout residency, Dr. Oaxaca dedicated his service time to various patient safety and resident pathology committees. He held resident member and representative positions for the Pathology and Laboratory Medicine Institute and the Cleveland Clinic, including AP Chief Resident. Additionally, he performed sample identification and tissue micro-array quality assessment for CAP proficiency testing.

As a premier, up-and-coming Pathologist, Dr. Oaxaca holds an impressive portfolio of research publications, abstracts, and teaching presentations.

Education

Fellowship Training

Dermatopathology
Cleveland Clinic Foundation
Cleveland, OH

Residency Training

Anatomic & Clinical Pathology
Cleveland Clinic Foundation
Cleveland, OH

Medical School

Baylor College of Medicine
Houston, TX

Undergraduate

Rice University
Houston, TX

Board Certifications

Dermatopathology

The American Board of Pathology

Anatomic & Clinical Pathology

The American Board of Pathology

Memberships

American Society of Dermatopathology

College of American Pathologists

United States and Canadian Academy of Pathology

American Society of Clinical Pathologists

Research & Publications

Publications
  • Oaxaca G, Coffey A, Gannon F, Szigeti R. Low-grade Epstein-Barr virus positive plasma cell proliferations of precursor plasma cell origin: report of two cases. International Journal of Clinical and Experimental Medicine. 2017; 10 (7): 11073-11078.
  • Oaxaca G, Billings SD, Ko JS. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma. J Cutan Pathol. 2020 Sep;47(9):815-823. doi: 10.1111/cup.13721. Epub 2020 Jul 6. PMID: 32330325.
  • Dermawan, J.K., Azzato, E.M., Billings, S.D. et al. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases. Mod Pathol (2021). https://doi.org/10.1038/s41379-021-00879-7
  • Frew D, Oaxaca G, Unwala R, Bergfeld WF. Plasma cell- predominant lichen planopilaris. American Journal of Dermatopathology. 2021. in-press.
Abstracts
  • Oaxaca G, Billings S, Ko J. Ischemic Fasciitis of the Upper extremity: A series of 14 Cases Highlighting an Unusual Presentation. Poster Presentation, USCAP, March 23, 2022.
  • Frew D, Duckworth L, McAfee J, Sharma A, Cook E, Oaxaca G, Billings S, Ronen S, Ko J. Intelligent use of Immunohistochemistry to Assess Sentinel Lymph Nodes for Occult Melanoma with Increased Efficiency. Poster Presentation, USCAP, March 22, 2022.
  • Sharma A, Oaxaca G, Cook E, Duckworth L, Frew D, McAfee J, Funchain P, Billings S, Ronen S, Ko J. Correlation Between Gene Expression Profiling, Sentinel Lymph Node Biopsy, and Metastatic Risk in Primary Cutaneous Melanoma Cases – A Series of 206 Cases. Poster Presentation, USCAP, March 22, 2022.
  • Oaxaca G, Billings S, Ko J. Superficial Desmoplastic Fibroblastoma: A series of 15 cases. Poster Presentation, American Society of Dermatopathology, October 23, 2021.
  • Sardina L, Oaxaca G, Agrawal S, Billings S. Cutaneous Malignant Myopericytoma: A Case report. Poster Presentation, American Society of Dermatopathology, October 23, 2021.
  • Duckworth LA, Santos Martins C, Bakhshwin A, Fuller L, Oaxaca G, Shetty S, AlHilli Z, Downs-Kelly E, Komforti, MK. Application and Adherence to Z0011 in the Surgical Management of Axillary Lymph Nodes in Breast Conserving Surgery: A Single Institution’s Experience. Poster Presentation, Cleveland Clinic Patient Safety Day 2021, March 10, 2021.
  • Oaxaca G, Dekmowicz R, Novotny A, Korty K, Sapatnekar S. Platelet Refractoriness in Transfusion Medicine. Poster Presentation, Cleveland Clinic Patient Safety Day 2020, March 11, 2020.
  • Oaxaca G, Uberti M, Bergfeld W. Unusual presentation of sclerosing dermatitis –Clinical mimics of breast carcinoma. Poster presentation, American Society of Dermatopathology Annual Meeting, October 18, 2019.
  • Oaxaca G, Rubin B, Ko J, Billings S. YAP1-TFE3 Epithelioid Hemangiodendothelioma. Platform presentation, Duel in Dermatopathology, American Society of Dermatopathology Annual meeting, October 19, 2019.
  • Oaxaca G, Feasel P, Billings S, Ko J. Early lichen sclerosus – an institutional study of histologic clues in the presclerotic phase. Poster presentation, American Society of Dermatopathology Annual Meeting, November 8th, 2018.
  • Oaxaca G, Billings S, Ko J. P16 Range of expression in benign epithelioid and spindled nevi and melanoma. Platform presentation, American Society of Dermatopathology Annual Meeting, November 10th, 2018.
  • Oaxaca G, Zhang H, Cortes-Penfield N, Constantine G, Hoonmo K. That Which Not Only Bends Up. Poster Presentation, Society of General Internal Medicine Southern Region Annual Meeting, May 2016.
Teaching Presentations
  • Dermatopathology Lecture Series. Cleveland Clinic Foundation. June 2021- April 2022.
  • “COVID Coagulopathy.” House Staff Seminar, Cleveland Clinic Foundation. October 17, 2020
  • “Platelet Refractoriness in Transfusion Medicine.” Pathology and Lab Medicine Institute Quality and Patient Safety Grand Rounds, Cleveland Clinic. December 12, 2019.
  • “Immunofluorescence-based approach to membranoproliferative glomerulonephropathies for optimal clinical correlation” House Staff Seminar, Cleveland Clinic Foundation. November 4, 2019.
  • Dermatopathology tumor board. Cleveland Clinic Foundation. March 26, 2019.
  • “Renal Function Tests.” Clinical Chemistry, Cleveland Clinic Foundation. March 19, 2019.
  • Lymphoma tumor board. Cleveland Clinic Foundation. 2019-2021.
  • “Making the Diagnosis: Plasmodium Species.” Microbiology, Cleveland Clinic Foundation. December 14, 2018.
  • “Daratumumab and its Impact on Laboratory Testing.” House Staff Seminar, Cleveland Clinic Foundation. December 11, 2018.
  • “Making the Diagnosis: Morphology of Intestinal Amoebae.” Microbiology, Cleveland Clinic Foundation. November 30, 2018.
  • “Making the Diagnosis: Dematiaceous Molds.” Microbiology, Cleveland Clinic Foundation. November 16, 2018.
  • “Making the Diagnosis: Dimorphic Fungi.” Microbiology, Cleveland Clinic Foundation. October 5, 2018.
  • “Making the Diagnosis. Thermally Monomorphic Hyaline Molds.” Microbiology, Cleveland Clinic Foundation. September 28, 2018.
  • “Making the Diagnosis: Dermatophytes.” Microbiology, Cleveland Clinic Foundation. September 21, 2018.
  • “Sebaceous Neoplasms.” House Staff Seminar, Cleveland Clinic Foundation. May 21, 2018.